Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
America's Affordable Health Choices Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
America's Affordable Health Choices Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2010 · first_quarter · 1A
Issues related to domestic supply of Moly-99 and conversion from HEU to LEU; HR 3276, American Medical Isotopes Production Act; Issues related to medical radiation.
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
Source: Senate LDA
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
American Medical Isotopes Production Act of 2010
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Issues related to domestic supply of Moly-99 and conversion from HEU to LEU; HR 3276, American Medical Isotopes Production Act; Issues related to medical radiation.
American Medical Isotopes Production Act of 2010
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Issues related to domestic supply of Moly-99 and conversion from HEU to LEU; HR 3276, American Medical Isotopes Production Act; Issues related to medical radiation.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
Service Members' Homebuyer Tax Credit Extension Act 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
Service Members' Homebuyer Tax Credit Extension Act 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
An Act to extend expiring provisions of the USA PATRIOT Improvement and Reauthorization Act of 2005 and Intelligence Reform and Terrorism Prevention Act of 2004 until February 28, 2011.
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
An Act to extend expiring provisions of the USA PATRIOT Improvement and Reauthorization Act of 2005 and Intelligence Reform and Terrorism Prevention Act of 2004 until February 28, 2011.
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
Affordable Health Choices Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
Affordable Health Choices Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
American Middle Class Tax (AMT) Relief Act of 2007
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
American Middle Class Tax (AMT) Relief Act of 2007
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Medicare reimbursement for imaging services and certification of imaging technicians; health care reform as it pertains to imaging; S 1679/HR 3200, America's Affordable Health Choices Act of 2009; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the physician Fee Schedule; HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
FY 2011 Appropriations for DOE Nuclear Medicine Research Program and Isotope Production
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2010 · first_quarter · Q1
Medicare reimbursement for imaging servcies and certification of imaging technicians; health care reform legislation as it pertains to imaging; S1679/HR3200, America's Affordable Health Choices Act of 2009; HR 3590, the Patient Protection and Affordable Health Care Act; HR 3780, Healthcare Reform Provisions; HR 3961 Medicare Physician Payment Reform Act, issues related to nuclear medicine reimbursement under the Physician Fee Schedule; HR 3652, the Consistenc, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009.
FY2011 Appropriations for DOE Nuclear Medicine Research Program and Isotope Production
Issues related to domestic supply of Moly-99 and conversion from HEU to LEU; HR 3276, American Medical Isotopes Production Act; Issues related to medical radiation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2010 · first_quarter · RR
Medical isotope production, DOE funding, Comments on proposed NRC, FDA and CMS regulations
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · fourth_quarter · 4A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · third_quarter · 3A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · second_quarter · 2A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC, FDA and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · first_quarter · 1A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · fourth_quarter · Q4
Medical Isotope Production DOE Funding Comments on proposed NRC, FDA and CMS regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · third_quarter · Q3
Medical Isotope Production DOE Funding Comments on proposed NRC, FDA and CMS regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · second_quarter · Q2
Medical Isotope Production DOE Funding Comments on proposed NRC, FDA and CMS regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009 · first_quarter · Q1
Medical Radioisotope Production DOE Funding Comments on proposed NRC and CMS regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · fourth_quarter · 4A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · third_quarter · 3A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · second_quarter · 2A
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC Regulations
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · first_quarter · 1A
Medical Radioisotope Production Issues DOE Funding Comments on NRC Proposed Regulations
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC)
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · fourth_quarter · Q4
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · third_quarter · Q3
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC and CMS regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · second_quarter · Q2
Medical Radioisotope Production Issues DOE Funding Comments on proposed NRC Regulatiopns
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008 · first_quarter · Q1
Medical Radioisotope Production Issues DOE Funding Comments on NRC Proposed Regulations
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2007 · year_end · YY
Medical Radioisotope Production Issues DOE Funding Comments on NRC Proposed Regulations Comments on Draft RDRC Guidance Documents
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2007 · mid_year · MM
Discussions of present and future availability of Radioisotopes for Medical Research. Discussions of reinstitution of funding for Nuclear Medicine Research. Society comments on various NRC proposed regulations. Medical Radioisotope Production Issues DOE Funding (Nuclear Medicine Research) Comments on NRC Proposed Regulations
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2006 · year_end · YY
Medical Radioisotope Production Issues Comments on Draft Guidance on Exploratory IND and RDRC DOE Funding Comments on NRC Proposed Regulations
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2005 · year_end · YY
Medical Radioisotope Production Issues Draft Guidance on Exploratory IND and RDRC DOE funding
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE